当前位置: 首页 >> 检索结果
共有 82575 条符合本次的查询结果, 用时 11.3403547 秒

341. CONSORT 2025 Statement: Updated Guideline for Reporting Randomized Trials.

作者: Sally Hopewell.;An-Wen Chan.;Gary S Collins.;Asbjørn Hróbjartsson.;David Moher.;Kenneth F Schulz.;Ruth Tunn.;Rakesh Aggarwal.;Michael Berkwits.;Jesse A Berlin.;Nita Bhandari.;Nancy J Butcher.;Marion K Campbell.;Runcie C W Chidebe.;Diana Elbourne.;Andrew Farmer.;Dean A Fergusson.;Robert M Golub.;Steven N Goodman.;Tammy C Hoffmann.;John P A Ioannidis.;Brennan C Kahan.;Rachel L Knowles.;Sarah E Lamb.;Steff Lewis.;Elizabeth Loder.;Martin Offringa.;Philippe Ravaud.;Dawn P Richards.;Frank W Rockhold.;David L Schriger.;Nandi L Siegfried.;Sophie Staniszewska.;Rod S Taylor.;Lehana Thabane.;David Torgerson.;Sunita Vohra.;Ian R White.;Isabelle Boutron.
来源: JAMA. 2025年333卷22期1998-2005页
Well-designed and properly executed randomized trials are considered the most reliable evidence on the benefits of health care interventions. However, there is overwhelming evidence that the quality of reporting is not optimal. The CONSORT (Consolidated Standards of Reporting Trials) statement was designed to improve the quality of reporting and provides a minimum set of items to be included in a report of a randomized trial. CONSORT was first published in 1996, then updated in 2001 and 2010. Herein, we present the updated CONSORT 2025 statement, which aims to account for recent methodological advancements and feedback from end users.

342. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?-Reply.

作者: Paul Dark.;Anower Hossain.;Ranjit Lall.
来源: JAMA. 2025年333卷19期1730-1731页

343. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Mattia Arrigo.;Lars C Huber.
来源: JAMA. 2025年333卷19期1729页

344. Drug Decriminalization in British Columbia and Changes in Drug Crime and Opioid and Stimulant Harms.

作者: Adrienne Gaudreault.;Robert Talarico.;Matthew Herder.;Daniel T Myran.
来源: JAMA. 2025年333卷21期1922-1925页

345. Use of Life Support and Outcomes Among Patients Admitted to Intensive Care Units.

作者: Emily E Moin.;Nicholas J Seewald.;Scott D Halpern.
来源: JAMA. 2025年333卷20期1793-1803页
Nationwide data are unavailable regarding changes in intensive care unit (ICU) outcomes and use of life support over the past 10 years, limiting understanding of practice changes.

346. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Chi-Kuei Hsu.;Chih-Cheng Lai.
来源: JAMA. 2025年333卷19期1728-1729页

347. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Nicholas A Bosch.;Kevin C Wilson.;Anica C Law.
来源: JAMA. 2025年333卷19期1728页

348. Why Good Palliative Care Clinicians Get Fired.

作者: Abby R Rosenberg.;Elliot Rabinowitz.;Robert M Arnold.
来源: JAMA. 2025年333卷21期1864-1865页

349. Are Procalcitonin Measures a Reliable Predictor of Stopping Antibiotics Among Patients With Sepsis?

作者: Xianshi Zhou.;Xiaotu Xi.;Huiyan Zeng.
来源: JAMA. 2025年333卷19期1729-1730页

350. Cataracts: A Review.

作者: Stephanie P Chen.;Fasika Woreta.;David F Chang.
来源: JAMA. 2025年333卷23期2093-2103页
Age-related cataract, defined as progressive opacification or clouding of the eye's natural lens, is a leading cause of visual disability and blindness. Cataract surgery is one of the most commonly performed procedures in high-income countries. More than 3.5 million cataract operations are performed annually in the US.

351. Rise in Vaping Keeps Tobacco Use High.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1570页

352. Clinicians' PTO Undermined by Patient Portal Work, Study Finds.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1570页

353. Kidney Disease Recommendations Advise SGLT2 Inhibitors for All Patients.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1571页

354. Abortion Bans Tied to Drop in OB-GYN Workforce in States With Restrictions.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1570页

355. Hemorrhage Causes Most Maternal Deaths Worldwide.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1570-1571页

356. FDA Approves Generic Form of Rivaroxaban for CAD and PAD.

作者: Samantha Anderer.
来源: JAMA. 2025年333卷18期1570页

357. How Dismantling DEI Efforts Could Make Clinical Trials Less Representative.

作者: Rita Rubin.
来源: JAMA. 2025年333卷18期1566-1569页

358. The Fourth of July-A Warning.

来源: JAMA. 2025年333卷17期1552页

359. Anterior Cruciate Ligament Injuries in Female Athletes.

作者: Kristin L Walter.
来源: JAMA. 2025年333卷18期1648页
共有 82575 条符合本次的查询结果, 用时 11.3403547 秒